Statera

Hamden, CTLife SciencesCohort: 2019-2020

Statera Therapeutics is developing a unique  immunotherapy delivery platform addressing autoimmune diseases. Statera’s engineered polymer nanoparticle delivers multiple therapeutic payloads (antigen/proteins and small molecule drugs) to targeted cells in a preferred sequence to elicit proper immune response in autoimmunity.

statera-therapeutics.com